Currently, there are 176.84M common shares owned by the public and among those 174.89M shares have been available to trade.
The company’s stock has a 5-day price change of -33.97% and -54.72% over the past three months. VXRT shares are trading -8.31% year to date (YTD), with the 12-month market performance down to -39.78% lower. It has a 12-month low price of $0.53 and touched a high of $1.54 over the same period. VXRT has an average intraday trading volume of 2.66 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -35.85%, -36.44%, and -38.31% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Vaxart Inc (NASDAQ: VXRT) shares accounts for 22.78% of the company’s 176.84M shares outstanding.
It has a market capitalization of $92.88M and a beta (3y monthly) value of 0.65. The earnings-per-share (ttm) stands at -$0.53. Price movements for the stock have been influenced by the stock’s volatility, which stands at 15.87% over the week and 10.06% over the month.
Earnings per share for the fiscal year are expected to increase by 2.92%, and 10.24% over the next financial year.
Looking at the support for the VXRT, a number of firms have released research notes about the stock. Jefferies stated their Buy rating for the stock in a research note on December 29, 2021, with the firm’s price target at $13-$12. Cantor Fitzgerald coverage for the Vaxart Inc (VXRT) stock in a research note released on November 02, 2021 offered a Overweight rating with a price target of $15. B. Riley Securities was of a view on June 29, 2021 that the stock is Neutral, while Jefferies gave the stock Buy rating on June 24, 2021, issuing a price target of $13. Piper Sandler on their part issued Overweight rating on June 11, 2021.
